News items related to: Patent challenges
-
Activists at AIDS2024 called on ViiV Healthcare to drop their case in Colombia against Compulsory License on Dolutegravir
On the 24th of July, hundreds of treatment advocates attending AIDS2024 in Munich protested against the companies with “Drop The...
-
The Rejection of the Bedaquiline Patent Opposition in Indonesia Raises the Risk of Difficulty in Accessing Optimal TB Therapy
The Indonesia AIDS Coalition (IAC) and Indonesia for Global Justice (IGJ) have filed a patent opposition for the Tuberculosis (TB)...
-
Activists File Patent Opposition to Challenge COVID-19 Drug Monopoly on Baricitinib
Activists from Morocco, Thailand, and Vietnam have filed patent oppositions to challenge drug manufacturers Incyte and Eli Lilly over the...
-
COVID-19 pandemic: ‘An opportunity of a lifetime’?
The race is on to find an effective treatment and vaccine for COVID-19. Everyone hopes a solution will be...
-
Possible treatments for COVID-19 could all be made for $1 a day, say researchers: Pharma must not profit from a pandemic and countries must ACT NOW.
Drugs currently being used in COVID-19 treatment trials can all be mass-produced affordably, research from the University of Liverpool, published...
-
“People with TB were being routinely imprisoned.” Overhauling Kenya’s TB response, and what the country’s impending COVID-19 crisis can adopt from it.
Our campaign partner, KELIN, has helped transform how people living with TB are treated. Their work set a precedent, ending...
-
We can’t end AIDS without tackling patent abuse
Despite significant scientific advancements for HIV, along with global and national commitments to ‘end AIDS’, hundreds of thousands of people...
-
Removing barriers to affordable treatment: Communities at the centre
The work of our campaign partner in Argentina, Fundación Grupo Efecto Positivo (FGEP), has been documented in UNAIDS’ Global AIDS...
-
The problem with patents: Commitments to HIV and universal health coverage are being undermined in middle-income countries
A joint blog by Othoman Mellouk, Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC),...
-
Ukraine: First civil society organization to oppose Merck’s patent application ( MK-8591) on the grounds of “obviousness”
On 28 May 2019, 100 Percent Life (the Network) submitted an opposition to the Ukrainian Patent and Trademark Office against...
-
Activists file post-grant opposition challenging a patent preventing purchase of cheaper treatment for hepatitis C
GTPI has presented an argument to the Brazilian Patent Office (INPI) to invalidate the patent granted for the drug daclatasvir....
